Unlocking the Psychedelic Mind: How DMT Transforms Brain Dynamics Through Serotonin Gateways

In a groundbreaking study that bridges consciousness, mathematics, and molecular neuroscience, researchers have revealed how the powerful psychedelic DMT (N,N-dimethyltryptamine) reshapes the brain’s dynamic architecture. The study, published in Communications Biology, offers the most detailed glimpse yet into how this fast-acting compound transforms the brain’s activity patterns—and what that means for the psychedelic experience.

At the heart of this discovery lies a curious phenomenon: under the influence of DMT, the brain requires significantly less energy to shift between states of activity. This decrease in “control energy,” as described through a mathematical lens known as network control theory, suggests that DMT enables the brain to operate in a more fluid and exploratory mode. The effect is not random—it closely aligns with the brain’s serotonin 2a receptor distribution, highlighting this receptor’s central role in facilitating DMT’s mind-expanding effects.

“Do you ever wonder what’s going on in the brain when someone is on DMT? Well, so do we,” said study lead author Dr. S. Parker Singleton, a postdoctoral fellow at PennLINC, University of Pennsylvania’s Perelman School of Medicine. “There’s a lot happening and we’re still working to understand what it all means.”

The Gateway Molecule

DMT, often dubbed the “spirit molecule,” is renowned for inducing vivid hallucinations and deeply immersive states of altered consciousness. Found naturally in some plants and prominently used in the South American ayahuasca tradition, DMT produces an intense but short-lived experience. When injected intravenously, its effects peak within seconds and subside within about 20 minutes—a feature that makes it ideal for use in neuroimaging studies such as fMRI and EEG, where capturing transient states is crucial.

In this new study, 20 healthy volunteers participated in a carefully designed experiment involving two sessions—one with DMT and another with a saline placebo—conducted two weeks apart. Each session included a 28-minute fMRI and EEG recording. Eight minutes into the scan, DMT or placebo was administered, allowing researchers to track brain changes in real-time. Participants also rated their experience intensity minute-by-minute, providing a rich dataset to compare neurobiology with lived subjective experience.

A Brain in Motion

The research team applied network control theory to quantify how much “effort” the brain requires to move from one activity state to another. Under DMT, this control energy decreased consistently across time points and brain regions. In practical terms, this meant that the brain became more agile—able to transition between patterns of activity with greater ease.

“This reduced energy requirement likely supports the brain’s ability to enter unfamiliar or unusual states of consciousness,” explained Singleton. “It’s as if the brain’s internal landscape becomes more navigable, more open to exploration.”

And this wasn’t just a theoretical insight. The drop in control energy was directly related to two hallmark features of the psychedelic state: increased signal diversity—a measure of how complex and unpredictable brain activity becomes—and the intensity of subjective experience reported by participants.

Mapping the Psychedelic Terrain

The most pronounced energy reductions were observed in specific brain networks that psychedelics are known to affect: the visual system, the frontoparietal network (linked to attention and cognitive control), and the default mode network (implicated in self-referential thought). Interestingly, the temporal evolution of these effects varied. Changes in the frontoparietal and default mode networks peaked early in the trip, while the visual system displayed more sustained alterations that appeared later in the experience.

“We found what I believe to be a pretty convincing arousal (vigilance) effect in the visual cortex during the later stages of the scan,” Singleton noted. “We likely would not have caught this without our time-resolved approach.”

Delving even deeper, the researchers cross-referenced their control energy maps with serotonin receptor distribution maps derived from previous PET imaging studies. The findings were striking: regions with higher concentrations of serotonin 2a receptors showed larger reductions in control energy, stronger increases in signal diversity, and more intense subjective experiences. A dominance analysis of several serotonin receptor types confirmed serotonin 2a as the most critical predictor of DMT’s brain effects.

Simulating the Psychedelic State

In an innovative twist, the team attempted to simulate the effects of DMT on the brain using only placebo brain data, serotonin receptor maps, and a pharmacological model of drug concentration over time. The resulting predictions closely mirrored the actual changes seen under DMT, suggesting that it may be possible to forecast how different psychoactive compounds might affect brain dynamics—before they’re even administered.

This simulation marks a bold step toward precision psychedelic neuroscience. If researchers can predict how various compounds will interact with specific brain regions based on receptor density and chemical properties, it could dramatically accelerate the development of targeted psychedelic therapies for conditions like depression, PTSD, and anxiety.

A New Vision of Consciousness

This study paints a compelling picture of the psychedelic state not as chaotic or uncontrolled, but as a more adaptive and fluid mode of brain function. Under DMT, the brain becomes an explorer, wandering more freely across the landscape of mental possibility. This exploration may underpin the profound emotional, visual, and cognitive transformations people report after a DMT experience.

“Expanded consciousness may be intimately tied to this flexibility,” said Singleton. “By reducing the brain’s control energy, psychedelics like DMT might allow us to access experiences—and perhaps even insights—that are otherwise inaccessible in ordinary waking states.”

Challenges and Horizons

Despite the revelatory findings, the study has its limitations. The sample size was relatively small, and the analysis relied on a group-average brain network rather than individual structural connectomes. Additionally, the single-blind design—where participants might guess which condition they were in—could introduce subtle biases. The authors acknowledge these challenges and stress the need for larger, double-blind studies that incorporate individual brain mapping.

Still, the study opens new doors. It reinforces the central role of serotonin 2a receptors in shaping psychedelic experiences and offers a framework for understanding how these molecules alter consciousness at both a molecular and systems level.

“We still have a lot to learn about psychedelic action in the brain,” Singleton emphasized. “Ongoing work seeks to address many potential confounds, including influences of arousal, head motion, and these drugs’ ability to impact the tone of blood vessels.”

As the psychedelic renaissance continues to unfold, studies like this one push the frontier forward—not only in terms of neuroscience and mental health but in our very understanding of what it means to be conscious.

Reference: Singleton, S. P., Timmermann, C., Luppi, A. I., Eckernäs, E., Roseman, L., Carhart-Harris, R. L., & Kuceyeski, A. (2025). Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience. Communications Biology.

This article contains AI generated content using information from these sources:
PsyPost - https://www.psypost.org/scientists-reveal-how-dmt-alters-brain-activity-and-consciousness-by-lowering-control-energy/